Clinical Trials Directory

Trials / Completed

CompletedNCT03935542

Assessment of Diagonal Branch Territory

Anatomical Attributes of Clinically Relevant Diagonal Branches in Patients With Left Anterior Descending Coronary Artery Bifurcation Lesions

Status
Completed
Phase
Study type
Observational
Enrollment
355 (actual)
Sponsor
Bon-Kwon Koo · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

This study was performed to investigate the anatomical attributes that determine myocardial territory of diagonal branches and to develop a prediction model for clinically relevant branches using myocardial perfusion imaging (MPI) and coronary CT angiography (CCTA).

Detailed description

Bifurcation lesion is one of the most challenging lesion subsets in the field of percutaneous coronary intervention (PCI). Despite the recent advances in PCI techniques and stent technology, most randomized studies failed to prove the superiority of systematic 2 stenting strategy compared with provisional side branch intervention strategy. A certain amount of ischemic burden is required to achieve the benefit of revascularization over medical treatment. Compared with major epicardial vessels, side branches are smaller, more variable in anatomy, supplying less myocardium and less clinically relevant. Therefore, it is important to assess the myocardial mass at risk of side branches to determine the appropriate treatment strategy for bifurcation lesions. However, how to define the clinically relevant side branches which can be associated with the benefit of revascularization in a cardiac catheterization laboratory is not well-known. The investigators performed this study to investigate the anatomical attributes that determine ischemic burden and myocardial territory of diagonal branches and to develop a prediction model for a clinically relevant diagonal branch using myocardial perfusion imaging (MPI) and coronary CT angiography (CCTA).

Conditions

Timeline

Start date
2015-08-03
Primary completion
2017-02-06
Completion
2018-10-08
First posted
2019-05-02
Last updated
2019-05-02

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03935542. Inclusion in this directory is not an endorsement.